64 related articles for article (PubMed ID: 2331166)
21. [Post-operative recurrence patterns of urothelial tumors in the upper urinary tract: comparison between renal pelvic and ureteral tumors].
Sengiku A; Nishiyama H; Shimizu T; Watabe J; Soda T; Kamba T; Yoshimura K; Kanematsu A; Nakamura E; Kamoto T; Ogawa O
Hinyokika Kiyo; 2008 Nov; 54(11):703-9. PubMed ID: 19068723
[TBL] [Abstract][Full Text] [Related]
22. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience.
Daneshmand S; Quek ML; Huffman JL
Cancer; 2003 Jul; 98(1):55-60. PubMed ID: 12833455
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
26. [Percutaneous treatment of tumors of the upper urinary tract].
Ballanger P
Ann Urol (Paris); 1988; 22(4):282-6. PubMed ID: 3190168
[TBL] [Abstract][Full Text] [Related]
27. Long-term results and management of ureteral transitional cell carcinoma using the holmium: YAG laser via rigid-ureteroscopy.
Yamada Y; Inoue Y; Nakamura K; Naruse K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hara K; Kato Y; Watanabe M; Hayashida K; Suzuki Y; Kato H; Ajisaka R; Kyoku I; Noguchi H; Honda N
Oncol Rep; 2009 Feb; 21(2):345-9. PubMed ID: 19148506
[TBL] [Abstract][Full Text] [Related]
28. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
30. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
[TBL] [Abstract][Full Text] [Related]
31. Tumours of the ureter and renal pelvis treated with resection and renal autotransplantation: a study with up to 20 years of follow-up.
Holmäng S; Johansson SL
BJU Int; 2005 Jun; 95(9):1201-5. PubMed ID: 15892801
[TBL] [Abstract][Full Text] [Related]
32. [Long-term results of surgical treatment for renal pelvic and ureteral tumors].
Yokoyama M; Kano M; Sakai M; Oda H; Inoue K; Kitahara K; Kanemura M; Osada M
Hinyokika Kiyo; 1995 Oct; 41(10):761-6. PubMed ID: 8533670
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous nephroscopic resection of renal pelvic tumors.
Fuglsig S; Krarup T
Scand J Urol Nephrol Suppl; 1995; 172():15-7. PubMed ID: 8578249
[TBL] [Abstract][Full Text] [Related]
34. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
35. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
36. Consideration for treatment of upper urinary tract tumors with topical therapy.
Huffman JL; Morse MJ; Herr HW; Whitmore WF
Urology; 1985 Oct; 26(4 Suppl):47-50. PubMed ID: 4049628
[TBL] [Abstract][Full Text] [Related]
37. Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation.
Yossepowitch O; Lifshitz DA; Dekel Y; Ehrlich Y; Gur U; Margel D; Livne PM; Baniel J
J Urol; 2005 Mar; 173(3):890-3. PubMed ID: 15711312
[TBL] [Abstract][Full Text] [Related]
38. [Antegrade and retrograde endourological techniques. Equipment and methodology].
Fernández González I; Serrano Pascual A; García Cuerpo E; Berenguer Sánchez A; Lovaco Castellano F
Arch Esp Urol; 2004 Apr; 57(3):251-8. PubMed ID: 15174503
[TBL] [Abstract][Full Text] [Related]
39. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract.
Komatsu H; Tanabe N; Kubodera S; Maezawa H; Ueno A
J Urol; 1997 May; 157(5):1622-4. PubMed ID: 9112490
[TBL] [Abstract][Full Text] [Related]
40. [The neodymium:YAG laser in infiltrating bladder tumors].
Spitzenpfeil E; Hofstetter A; Reis M; Muschter R
Fortschr Med; 1989 Sep; 107(26):548-51. PubMed ID: 2807117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
